1-6 of 6
Bartosz Chmielowski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

Available to Purchase
Kenneth F. Grossmann, Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp, Teresa M. Petrella, Thach-Giao Truong, Nikhil I. Khushalani, Justine V. Cohen, Elizabeth I. Buchbinder, Kari Kendra, Pauline Funchain, Karl D. Lewis, Robert M. Conry, Bartosz Chmielowski, Ragini R. Kudchadkar, Douglas B. Johnson, Hongli Li, James Moon, Zeynep Eroglu, Brian Gastman, Magdalena Kovacsovics-Bankowski, Krishna S. Gunturu, Scot W. Ebbinghaus, Sama Ahsan, Nageatte Ibrahim, Elad Sharon, Larissa A. Korde, John M. Kirkwood, Antoni Ribas
Journal: Cancer Discovery
Cancer Discov (2022) 12 (3): 644–653.
https://doi.org/10.1158/2159-8290.CD-21-1141
Published: 08 March 2022
View articletitled, Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma
Open the PDF for Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma in another window
Includes: Supplementary data
Journal Articles

Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma

Open Access
Antoni Ribas, Theresa Medina, John M. Kirkwood, Yousef Zakharia, Rene Gonzalez, Diwakar Davar, Bartosz Chmielowski, Katie M. Campbell, Riyue Bao, Heather Kelley, Aaron Morris, David Mauro, James E. Wooldridge, Jason J. Luke, George J. Weiner, Arthur M. Krieg, Mohammed M. Milhem
Journal: Cancer Discovery
Cancer Discov (2021) 11 (12): 2998–3007.
https://doi.org/10.1158/2159-8290.CD-21-0425
Published: 01 December 2021
View articletitled, Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma
Open the PDF for Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations

Free
Daniel Sanghoon Shin, Jesse M. Zaretsky, Helena Escuin-Ordinas, Angel Garcia-Diaz, Siwen Hu-Lieskovan, Anusha Kalbasi, Catherine S. Grasso, Willy Hugo, Salemiz Sandoval, Davis Y. Torrejon, Nicolaos Palaskas, Gabriel Abril Rodriguez, Giulia Parisi, Ariel Azhdam, Bartosz Chmielowski, Grace Cherry, Elizabeth Seja, Beata Berent-Maoz, I. Peter Shintaku, Dung T. Le, Drew M. Pardoll, Luis A. Diaz, Jr, Paul C. Tumeh, Thomas G. Graeber, Roger S. Lo, Begoña Comin-Anduix, Antoni Ribas
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2017) 7 (2): 188–201.
https://doi.org/10.1158/2159-8290.CD-16-1223
Published: 05 February 2017
View articletitled, Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
Open the PDF for Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations in another window
Includes: Supplementary data
Journal Articles

Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy

Free
Hubing Shi, Willy Hugo, Xiangju Kong, Aayoung Hong, Richard C. Koya, Gatien Moriceau, Thinle Chodon, Rongqing Guo, Douglas B. Johnson, Kimberly B. Dahlman, Mark C. Kelley, Richard F. Kefford, Bartosz Chmielowski, John A. Glaspy, Jeffrey A. Sosman, Nicolas van Baren, Georgina V. Long, Antoni Ribas, Roger S. Lo
Journal: Cancer Discovery
Cancer Discov (2014) 4 (1): 80–93.
https://doi.org/10.1158/2159-8290.CD-13-0642
Published: 07 January 2014
View articletitled, Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
Open the PDF for Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy in another window
Includes: Supplementary data
Journal Articles

Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy

Free
Chao Ma, Ann F. Cheung, Thinle Chodon, Richard C. Koya, Zhongqi Wu, Charles Ng, Earl Avramis, Alistair J. Cochran, Owen N. Witte, David Baltimore, Bartosz Chmielowski, James S. Economou, Begonya Comin-Anduix, Antoni Ribas, James R. Heath
Journal: Cancer Discovery
Cancer Discov (2013) 3 (4): 418–429.
https://doi.org/10.1158/2159-8290.CD-12-0383
Published: 10 April 2013
View articletitled, Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy
Open the PDF for Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Preexisting MEK1 Exon 3 Mutations in V600E/KBRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors

Free
Hubing Shi, Gatien Moriceau, Xiangju Kong, Richard C. Koya, Ramin Nazarian, Gulietta M. Pupo, Antonella Bacchiocchi, Kimberly B. Dahlman, Bartosz Chmielowski, Jeffrey A. Sosman, Ruth Halaban, Richard F. Kefford, Georgina V. Long, Antoni Ribas, Roger S. Lo
Journal: Cancer Discovery
Cancer Discov (2012) 2 (5): 414–424.
https://doi.org/10.1158/2159-8290.CD-12-0022
Published: 09 May 2012
View articletitled, Preexisting MEK1 Exon 3 Mutations in V600E/KBRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors
Open the PDF for Preexisting MEK1 Exon 3 Mutations in V600E/KBRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors in another window
Includes: Supplementary data